CADTH undertook a health technology assessment (HTA) to assess the evidence on proton beam therapy (PBT) for various types of cancer and to identify the issues related to referring patients abroad for PBT versus installing Canadian-based facilities. The HTA reviewed the clinical effectiveness, harms, and cost-effectiveness of PBT. Patient experiences, ethical issues, and implementation considerations of PBT were also examined.
The project has two key components:
- Protocol
- Science report